GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 451 - 475 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▼ Arbitrary Fluorescence Units (AFU)
IgA Patient 1 10 moderate
G89993FE
436
IgA Patient 1 22 moderate
G89993FE
364
IgA Patient 1 6 moderate
G89993FE
409
IgG Patient 1 10 moderate
G89993FE
25
IgG Patient 1 22 moderate
G89993FE
29
IgM Patient 1 10 moderate
G89993FE
46
IgM Patient 1 22 moderate
G89993FE
119
IgG Patient 1 6 moderate
G89993FE
26
IgM Patient 1 6 moderate
G89993FE
43
IgA Patient 2 15 mild
G89993FE
430
IgA Patient 2 24 mild
G89993FE
493
IgG Patient 2 15 mild
G89993FE
38
IgG Patient 2 24 mild
G89993FE
38
IgM Patient 2 15 mild
G89993FE
165
IgA Patient 2 3 mild
G89993FE
561
IgG Patient 2 3 mild
G89993FE
52
IgM Patient 2 24 mild
G89993FE
173
IgM Patient 2 3 mild
G89993FE
307
IgA Patient 3 -180 mild
G89993FE
313
IgA Patient 3 11 mild
G89993FE
410
IgG Patient 3 -180 mild
G89993FE
41
IgM Patient 3 -180 mild
G89993FE
73
IgA Patient 3 4 mild
G89993FE
399
IgG Patient 3 11 mild
G89993FE
42
IgG Patient 3 4 mild
G89993FE
40

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024